Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1963 Jun;98(6):308–312.

SYSTEMIC LUPUS ERYTHEMATOSUS—The Effect of Corticotropin and Adrenocorticoid Therapy on Survival Rate

Jack Posnick
PMCID: PMC1575752  PMID: 13985665

Abstract

Ninety-four cases of systemic lupus erythematosus (SLE) were reviewed to assess the effect of adrenocorticotropin and adrenocorticoids on survival rate. Of the 43 patients who died, the mean survival in treated cases was 4.7 years, compared with 2 years in the control group. Utilizing a modified life table method, five-year survival rates were calculated for patients with SLE classified according to the severity of symptoms at the onset of disease. Survival rates for the treated and control groups were similar for patients with mild SLE, but definitely favored the treated patients who had moderate or severe forms of the disease. Thus, corticotropin or adrenocorticoid therapy seems definitely indicated in the moderate and certainly in the severe cases of SLE.

Full text

PDF
308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CUTLER S. J., EDERER F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958 Dec;8(6):699–712. doi: 10.1016/0021-9681(58)90126-7. [DOI] [PubMed] [Google Scholar]
  2. DUBOIS E. L. Current therapy of systemic lupus erythematosus. A comparative evaluation of corticosteroids and their side-effects with emphasis on fifty patients treated with dexamethasone. JAMA. 1960 Aug 13;173:1633–1640. doi: 10.1001/jama.1960.03020330001001. [DOI] [PubMed] [Google Scholar]
  3. DUBOIS E. L. Methylprednisolone (medrol) in the treatment of systemic lupus erythematosus; analysis of results in forty cases. J Am Med Assoc. 1959 Jul 25;170(13):1537–1542. doi: 10.1001/jama.1959.03010130041011. [DOI] [PubMed] [Google Scholar]
  4. DuBOIS E. L., COMMONS R. R., STARR P., STEIN C. S., Jr, MORRISON R. Corticotropin and cortisone treatment for systemic lupus erythematosus. J Am Med Assoc. 1952 Jul 12;149(11):995–1002. doi: 10.1001/jama.1952.02930280017006. [DOI] [PubMed] [Google Scholar]
  5. HARVEY A. M., SHULMAN L. E., TUMULTY P. A., CONLEY C. L., SCHOENRICH E. H. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954 Dec;33(4):291–437. [PubMed] [Google Scholar]
  6. HASERICK J. R. Effect of cortisone and corticotropin on prognosis of systemic lupus erythematosus; survey of eighty-three patients with positive plasma L. E. tests. AMA Arch Derm Syphilol. 1953 Dec;68(6):714–725. doi: 10.1001/archderm.1953.01540120098014. [DOI] [PubMed] [Google Scholar]
  7. JESSAR R. A., LAMONT-HAVERS R. W., RAGAN C. Natural history of lupus erythematosus disseminatus. Ann Intern Med. 1953 Apr;38(4):717–731. doi: 10.7326/0003-4819-38-4-717. [DOI] [PubMed] [Google Scholar]
  8. KATZ S. Infectious disease emergencies. Med Clin North Am. 1962 Mar;46:473–486. doi: 10.1016/s0025-7125(16)33732-4. [DOI] [PubMed] [Google Scholar]
  9. KOELSCHE G. A., CARRYER H. M., PETERS G. A., HENDERSON L. L. Management of the seriously ill asthmatic. J Am Med Assoc. 1958 Mar 29;166(13):1541–1545. doi: 10.1001/jama.1958.02990130001001. [DOI] [PubMed] [Google Scholar]
  10. MELBY J. C. Adrenocorticosteroids in medical emergencies. Med Clin North Am. 1961 Jul;45:875–886. doi: 10.1016/s0025-7125(16)33850-0. [DOI] [PubMed] [Google Scholar]
  11. McCOMBS R. P., PATTERSON J. F. Factors influencing the course and prognosis of systemic lupus erythematosus. N Engl J Med. 1959 Jun 11;260(24):1195–1204. doi: 10.1056/NEJM195906112602401. [DOI] [PubMed] [Google Scholar]
  12. POLLAK V. E., KARK R. M., PIRANI C. L. Corticosteroid therapy in lupus nephritis. Importance of adequate dosage. Bull Rheum Dis. 1961 Apr;11:249–250. [PubMed] [Google Scholar]
  13. ROPES M. W. Conservative treatment in rheumatoid arthritis. Med Clin North Am. 1961 Sep;45:1197–1207. doi: 10.1016/s0025-7125(16)33828-7. [DOI] [PubMed] [Google Scholar]
  14. RUPE C. E., NICKEL S. N. New clinical concept of systemic lupus erythematosus. Analysis of 100 cases. J Am Med Assoc. 1959 Oct 24;171:1055–1061. doi: 10.1001/jama.1959.03010260011003. [DOI] [PubMed] [Google Scholar]
  15. SANDERS S. L., BRODEY M., NELSON C. T. Corticosteroid treatment of pemphigus. Experience with fifty cases over a period of ten years. Arch Dermatol. 1960 Nov;82:717–724. doi: 10.1001/archderm.1960.01580050059007. [DOI] [PubMed] [Google Scholar]
  16. SOFFER L. J., BADER R. Corticotropin and cortisone in acute disseminated lupus erythematosus; results of long-term use. J Am Med Assoc. 1952 Jul 12;149(11):1002–1008. doi: 10.1001/jama.1952.02930280024007. [DOI] [PubMed] [Google Scholar]
  17. SOFFER L. J., ELSTER S. K., HAMERMAN D. J. Treatment of acute disseminated lupus erythematosus with corticotropin and cortisone. AMA Arch Intern Med. 1954 Apr;93(4):503–514. doi: 10.1001/archinte.1954.00240280023003. [DOI] [PubMed] [Google Scholar]
  18. SOFFER L. J. The therapy of systemic lupus erythematosus. J Mt Sinai Hosp N Y. 1959 May-Jun;26(3):297–306. [PubMed] [Google Scholar]
  19. SPINK W. W. Adrenocortical steroids in the management of selected patients with infectious diseases. Ann Intern Med. 1960 Jul;53:1–32. doi: 10.7326/0003-4819-53-1-1. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES